ArteraAI, a developer of AI-based cancer tests, has partnered with CorePlus, a CLIA-certified pathology laboratory in Puerto Rico. The collaboration focuses on validating The ArteraAI Prostate Test within the Hispanic population.
We are thrilled to collaborate with ArteraAI to further the advancement and reduction of inequities in prostate cancer diagnosis and treatment,” said Mariano de Socarraz, CEO of CorePlus.
